Search ( Ctrl + / )
Dr. Reddy's Laboratories Ltd
RDYNYSE
RDYNYSE
RDYNYSE
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | |
|---|---|---|---|---|---|---|---|---|
| Statement Date | 12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
| Net Income | 2025 | 2025 | 2025 | 2024 | 2024 | 2024 | 2024 | 2023 |
| Depreciation and Amortization | 4.72B | 3.98B | 3.81B | 3.71B | 3.77B | 3.79B | 3.57B | 3.06B |
| Deferred Income Tax | 4.70B | 5.75B | 4.90B | 2.95B | 4.47B | 4.33B | 4.44B | 3.66B |
| Stock Based Compensation | 103.00M | 107.00M | 101.00M | 97.00M | 99.00M | 103.00M | 108.00M | 21.00M |
| Change in Working Capital | -9.65B | -7.78B | -13.14B | -2.76B | -11.86B | 2.61B | -8.17B | 2.48B |
| Accounts Receivables | -7.85B | -3.40B | -786.00M | -1.92B | -8.83B | 7.34B | -4.65B | 2.49B |
| Inventory | -1.06B | -5.01B | -6.32B | -3.90B | -5.20B | -4.70B | -4.64B | -4.21B |
| Accounts Payables | 0.00 | 0.00 | 0.00 | 0.00 | 8.83B | -7.34B | 4.65B | -2.49B |
| Other Working Capital | -737.00M | 620.00M | -6.03B | 4.56B | -6.65B | 7.31B | -3.54B | 6.69B |
| Other Non Cash Items | -7.30B | -6.15B | -1.10B | -54.00M | -5.53B | -7.71B | -2.72B | -14.55B |
| Net Cash Provided by Operating Activities | 6.62B | 9.32B | 8.50B | 11.52B | 4.74B | 17.93B | 11.25B | 19.68B |
| Investments in Property Plant and Equipment | -7.20B | -7.54B | -5.11B | -6.28B | -5.04B | -3.94B | -12.17B | -3.75B |
| Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 5.04B | 3.94B | 12.17B | 0.00 |
| Purchases of Investments | -54.08B | -76.59B | -61.74B | -40.31B | -35.17B | -40.40B | -29.61B | -48.46B |
| Sales Maturities of Investments | 56.31B | 115.72B | 47.27B | 34.77B | 23.20B | 38.65B | 33.16B | 36.19B |
| Other Investing Activities | -485.00M | -50.67B | -668.00M | -6.11B | -4.22B | -2.77B | -11.79B | 248.00M |
| Net Cash Used for Investing Activities | -5.46B | -19.07B | -20.25B | -11.35B | -16.18B | -4.52B | -8.24B | -15.77B |
| Debt Repayment | 1.52B | 16.56B | 10.27B | 0.00 | 0.00 | 0.00 | -991.00M | -15.25B |
| Common Stock Issued | 25.00M | 7.19B | 19.00M | 31.00M | 9.00M | 686.00M | 79.00M | 221.00M |
| Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividends Paid | 0.00 | -6.66B | 0.00 | 0.00 | 0.00 | -6.65B | 0.00 | 0.00 |
| Other Financing Activities | -956.00M | -937.00M | -744.00M | -564.00M | 5.27B | -1.07B | -564.00M | 10.73B |
| Net Cash Used Provided by Financing Activities | 590.00M | 16.15B | 9.54B | -533.00M | 5.28B | -7.04B | -1.48B | -4.30B |
| Effect of Forex Changes on Cash | -5.00M | -23.00M | 17.00M | -65.00M | 161.00M | -66.00M | -89.00M | -88.00M |
| Net Change in Cash | 1.75B | 6.37B | -2.19B | -428.00M | -6.00B | 6.31B | 1.45B | -480.00M |
| Cash at End of Period | 13.03B | 11.29B | 4.91B | 7.11B | 7.54B | 13.54B | 7.23B | 5.78B |
| Cash at Beginning of Period | 11.29B | 4.91B | 7.11B | 7.54B | 13.54B | 7.23B | 5.78B | 6.26B |
| Operating Cash Flow | 6.62B | 9.32B | 8.50B | 11.52B | 4.74B | 17.93B | 11.25B | 19.68B |
| Capital Expenditure | -8.82B | -7.91B | -6.42B | -6.28B | -5.04B | -3.94B | -12.17B | -3.75B |
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | |
|---|---|---|---|---|---|---|---|---|
| Statement Date | 12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
| Net Income | 2025 | 2025 | 2025 | 2024 | 2024 | 2024 | 2024 | 2023 |
| Depreciation and Amortization | 4.72B | 3.98B | 3.81B | 3.71B | 3.77B | 3.79B | 3.57B | 3.06B |
| Deferred Income Tax | 4.70B | 5.75B | 4.90B | 2.95B | 4.47B | 4.33B | 4.44B | 3.66B |
| Stock Based Compensation | 103.00M | 107.00M | 101.00M | 97.00M | 99.00M | 103.00M | 108.00M | 21.00M |
| Change in Working Capital | -9.65B | -7.78B | -13.14B | -2.76B | -11.86B | 2.61B | -8.17B | 2.48B |
| Accounts Receivables | -7.85B | -3.40B | -786.00M | -1.92B | -8.83B | 7.34B | -4.65B | 2.49B |
| Inventory | -1.06B | -5.01B | -6.32B | -3.90B | -5.20B | -4.70B | -4.64B | -4.21B |
| Accounts Payables | 0.00 | 0.00 | 0.00 | 0.00 | 8.83B | -7.34B | 4.65B | -2.49B |
| Other Working Capital | -737.00M | 620.00M | -6.03B | 4.56B | -6.65B | 7.31B | -3.54B | 6.69B |
| Other Non Cash Items | -7.30B | -6.15B | -1.10B | -54.00M | -5.53B | -7.71B | -2.72B | -14.55B |
| Net Cash Provided by Operating Activities | 6.62B | 9.32B | 8.50B | 11.52B | 4.74B | 17.93B | 11.25B | 19.68B |
| Investments in Property Plant and Equipment | -7.20B | -7.54B | -5.11B | -6.28B | -5.04B | -3.94B | -12.17B | -3.75B |
| Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 5.04B | 3.94B | 12.17B | 0.00 |
| Purchases of Investments | -54.08B | -76.59B | -61.74B | -40.31B | -35.17B | -40.40B | -29.61B | -48.46B |
| Sales Maturities of Investments | 56.31B | 115.72B | 47.27B | 34.77B | 23.20B | 38.65B | 33.16B | 36.19B |
| Other Investing Activities | -485.00M | -50.67B | -668.00M | -6.11B | -4.22B | -2.77B | -11.79B | 248.00M |
| Net Cash Used for Investing Activities | -5.46B | -19.07B | -20.25B | -11.35B | -16.18B | -4.52B | -8.24B | -15.77B |
| Debt Repayment | 1.52B | 16.56B | 10.27B | 0.00 | 0.00 | 0.00 | -991.00M | -15.25B |
| Common Stock Issued | 25.00M | 7.19B | 19.00M | 31.00M | 9.00M | 686.00M | 79.00M | 221.00M |
| Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividends Paid | 0.00 | -6.66B | 0.00 | 0.00 | 0.00 | -6.65B | 0.00 | 0.00 |
| Other Financing Activities | -956.00M | -937.00M | -744.00M | -564.00M | 5.27B | -1.07B | -564.00M | 10.73B |
| Net Cash Used Provided by Financing Activities | 590.00M | 16.15B | 9.54B | -533.00M | 5.28B | -7.04B | -1.48B | -4.30B |
| Effect of Forex Changes on Cash | -5.00M | -23.00M | 17.00M | -65.00M | 161.00M | -66.00M | -89.00M | -88.00M |
| Net Change in Cash | 1.75B | 6.37B | -2.19B | -428.00M | -6.00B | 6.31B | 1.45B | -480.00M |
| Cash at End of Period | 13.03B | 11.29B | 4.91B | 7.11B | 7.54B | 13.54B | 7.23B | 5.78B |
| Cash at Beginning of Period | 11.29B | 4.91B | 7.11B | 7.54B | 13.54B | 7.23B | 5.78B | 6.26B |
| Operating Cash Flow | 6.62B | 9.32B | 8.50B | 11.52B | 4.74B | 17.93B | 11.25B | 19.68B |
| Capital Expenditure | -8.82B | -7.91B | -6.42B | -6.28B | -5.04B | -3.94B | -12.17B | -3.75B |